Mark A. Wilson
2020
In 2020, Mark A. Wilson earned a total compensation of $3.5M as Senior Vice President and General Counsel at Nektar Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $270,000 |
|---|---|
| Option Awards | $1,071,122 |
| Salary | $500,000 |
| Stock Awards | $1,604,292 |
| Other | $10,492 |
| Total | $3,455,906 |
Wilson received $1.6M in stock awards, accounting for 46% of the total pay in 2020.
Wilson also received $270K in non-equity incentive plan, $1.1M in option awards, $500K in salary and $10.5K in other compensation.
Rankings
In 2020, Mark A. Wilson's compensation ranked 3,357th out of 13,090 executives tracked by ExecPay. In other words, Wilson earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,357 out of 13,090 | 74th |
Division Manufacturing | 1,306 out of 5,621 | 77th |
Major group Chemicals And Allied Products | 495 out of 2,254 | 78th |
Industry group Drugs | 429 out of 1,954 | 78th |
Industry Pharmaceutical Preparations | 322 out of 1,459 | 78th |
Source: SEC filing on April 30, 2021.
Wilson's colleagues
We found four more compensation records of executives who worked with Mark A. Wilson at Nektar Therapeutics in 2020.
2020
Howard Robin
Nektar Therapeutics
Chief Executive Officer
2020
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2020
Jonathan Zalevsky
Nektar Therapeutics
Chief Research and Development Officer
2020
John Northcott
Nektar Therapeutics